Gathering topics and reviewing the articles for our annual Top-of-Mind publication is always one of my favorite yearly endeavors, allowing me to talk to clients, colleagues and industry experts about the overall state of the life sciences industry. The timing of this publication usually coincides with the J.P. Morgan Healthcare Conference, providing a key opportunity to vet our articles. The breath and scope of comments, concerns, predictions have been remarkable.
Latest Post
More Posts
2024 Top-of-Mind Issues for Life Sciences Companies
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term
Federal Circuit Confirms Addition of Two Inventors of Groundbreaking Immunotherapies for Cancer
USPTO Provides Form for Claiming 30-Day COVID-19 Extensions
Congress Gives Patent and Trademark Office Temporary Authorization to Move Deadlines in Light of COVID-19 Pandemic
Federal Circuit Weighs in on Patent Subject-Matter Eligibility of Dietary Supplements
PTO Cancer Immunotherapy Fast Track
Subscribe: Subscribe via RSS